Obama brings hope for Indian generics and biotech sectors
This article was originally published in Scrip
Executive Summary
Democrat Barack Obama's victory in the US presidential elections has raised hopes of increased generic usage and clarity on a pathway for biosimilars in the US, both areas of significant interest for Indian pharmaceutical firms.